A Weak Link: Chinese Courts Reluctant To Grant Preliminary Injunctions In Pharma IP Cases
This article was originally published in PharmAsia News
Executive Summary
With a large number of pharma patents about to expire in China, hurdles to obtaining injunctive relief could be a huge problem, according to the EU Chamber of Commerce in China.